In BriefAn international summit of scientists concluded that human gene editing is ethical and appropriate, as long as it is not done for reproductive purposes.
Gene Editing Regulation Update
There have been a lot of controversies related to human gene editing, especially when it comes to editing human DNA. In recent times, these controversies have been pushed to the forefront of both ethical and scientific conversations, as the discovery of key proteins involved in DNA excision and technological developments have made precision DNA editing a reality.
The biggest breakthrough is, of course, the CRISPR/Cas9 system, which has become so cheap and easy to use that, very soon, it may be possible for anyone with a little know-how to use it at home to correct genetic diseases.
For people in the biomedical field, CRISPR is like a medical godsend. To many others, though, it calls to mind things like designer babies and a society where the rich are able to literally set themselves apart on a fundamental, genetic level. Ideas related to humanity “playing God” and doing something “unnatural” also about. Such fears, scientists worried, would lead to unnecessary limits on a number of forms of research.
But thanks to the International Summit on December 3, the issue has gotten a bit more green-light.
There, the U.S. National Academies of Sciences and Medicine, the Chinese Academy of Sciences, and the United Kingdom’s Royal Society convened to discuss the state of the science as well as ethical, legal, and regulatory considerations related to this discipline.
Ultimately, they concluded that human gene-editing research (even on embryos) is necessary and must continue…as long as no pregnancies occur.
Gene Editing Issues
Gene editing on somatic cells is already used in clinical studies. Earlier this month, a company claimed that clinical trials using gene editing to replace a broken gene in adult hemophiliacs could begin as early as next year. This would still fall under gene therapy.
However—from a moral, ethical, and safety position—such research, when done with germ cells, would be treated as “irresponsible” if such edited cells would be implanted in the uterus for reproductive purposes.
That said, The scientists at the summit did indicate that a ban, or even a moratorium, on gene editing was never decided upon. Instead, the recommendations would be revisited on a regular basis as research advances and societal opinions evolve.
In any case, it seems that, rather soon, you may not have to play your hand with the genetic cards that you were dealt.